References
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019 Nov;157:107843.
- Cho NH, Shaw JE, Karuranga S, Huang Y, Da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice. 2018 Apr;138:271–81.
- Bommer C, Sagalova V, Heesemann E, Manne-Goehler J, Atun R, Bärnighausen T, et al. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030. Diabetes Care. 2018 Feb 23;41(5):963–70.
- Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 Mar;87(3):293–301.
- Bommer C, Heesemann E, Sagalova V, Manne-Goehler J, Atun R, Bärnighausen T, et al. The global economic burden of diabetes in adults aged 20–79 years: a cost-of-illness study. The Lancet Diabetes & Endocrinology. 2017 Jun 1;5(6):423–30.
- Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, et al. Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2020 Apr 1 [cited 2024 Nov 5];10.2478/rjdnmd-2013-0017
- Fernandes J da R, Ogurtsova K, Linnenkamp U, Guariguata L, Seuring T, Zhang P, et al. IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Research and Clinical Practice. 2016 Jul 1;117:48–54.
- Moucheraud C, Lenz C, Latkovic M, Wirtz VJ. The costs of diabetes treatment in lowand middle-income countries: a systematic review. BMJ Global Health. 2019 Feb 1;4(1):e001258.
- Butt MD, Ong SC, Rafiq A, Kalam MN, Sajjad A, Abdullah M, et al. A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries. Journal of Pharmaceutical Policy and Practice. 2024 Dec 31;17(1):2322107.
- Mota M, Popa SG, Mota E, Mitrea A, Catrinoiu D, Cheta DM, et al. Prevalence of diabetes mellitus and prediabetes in the adult Romanian population: PREDATORR study. Journal of Diabetes. 2016;8(3):336–44.
- Vlad A, Serban V, Green A, Möller S, Vlad M, Timar B, et al. Time Trends, Regional Variability and Seasonality Regarding the Incidence of Type 1 Diabetes Mellitus in Romanian Children Aged 0-14 Years, Between 1996 and 2015. JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY. 2018;10(2):92–9.
- Mota M, Dinu IR. The Analysis of Prevalence and Incidence of Diabetes Mellitus in Romania. Romanian Journal of Diabetes Nutrition and Metabolic Diseases. 2013 Jun 1;20(2):135–9.
- Druică E, Goschin Z, Băicuș C. Regional socio-economic factors influencing diabetes incidence: the case of Romania. 2018;9.. ISSN:2068-6633
- Bala C, Rusu A, Ciobanu D, Roman G. Length of Hospital Stay, Hospitalization Costs, and Their Drivers in Adults with Diabetes in the Romanian Public Hospital System. International Journal of Environmental Research and Public Health. 2022 Jan;19(16):10035.
- Sima DI, Bondor CI, Vereşiu IA, Gâvan NA, Borzan CM. Hospitalization Costs of Lower Limb Ulcerations and Amputations in Patients with Diabetes in Romania. International Journal of Environmental Research and Public Health. 2021 Jan;18(5):2230.
- Morgovan C, Cosma SA, Valeanu M, Juncan AM, Rus LL, Gligor FG, et al. An Exploratory Research of 18 Years on the Economic Burden of Diabetes for the Romanian National Health Insurance System. International Journal of Environmental Research and Public Health. 2020 Jan;17(12):4456.
- https://ms.ro/ro/minister/organizare/programe-na%C8%9Bionale-des%C4%83n%C4%83tate/
- http://www.casan.ro/page/programul-national-de-diabet-zaharat.html
- ORDER No. 377/2017 of March 30, 2017, regarding the approval of the technical norms for implementing the national public health programs for the years 2017 and 2018.
- CNAS Address 8635/11.01.2024, regarding the status of the number of patients benefiting from the National Diabetes Program, the expenses, the average costs per beneficiary patient, and the status of funds allocated to the National Diabetes Program.
- Constanța Public Health Directorate Address 8206/11.05.2023, regarding the status of diabetes patients in Constanța County.
- Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023 Jul 15;402(10397):203–34.
- Serban V, Timar R, Dabelea D, Green A, McKinney P, Law G, et al. The epidemiology of childhood-onset type 1 diabetes mellitus in Romania. ONROCAD Study Group. National Romanian Organisation for the Care of Diabetic Children and Adolescents. J Pediatr Endocrinol Metab. 2001 May;14(5):535–41.
- https://societate-diabet.ro/2024/11/14/comunicat-de-presa-ziua-mondiala-adiabetului-2024/
- Chereches, R., Litan, C., Zlati, A., & Bloom, J. (2012). Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country. Journal of Mental Health Policy and Economics, 15, 127-138. | Request PDF. ResearchGate [Internet]. 2024 Oct 22 [cited 2024 Nov 24]; Available from: https://www.researchgate.net/publication/235948817_Chereches_R_Litan_C_Zlati_A_Bloom_J_2012_Does_co-morbid_depression_impact_diabetes_related_costs_Evidence_from_a_cross-sectional_survey_in_a_low-income_country_Journal_of_Mental_Health_Policy_and_Econ
- ORDER for amending and supplementing Order No. 1068/627/2021 of the Minister of Health and the President of the National Health Insurance House regarding the approval of the methodological norms for implementing Government Decision No. 696/2021 in 2021 for the approval of service packages and the framework contract regulating the conditions for providing medical care, medications, and medical devices within the social health insurance system for the years 2021–2022, as well as the extension of its provisions [Internet]. [cited 2024 Dec 2]. Available from: https://cnas.ro/wp-content/uploads/2022/01/Norme-COCA-28.01.2022-1.pdf.
- Oldenburg B, Absetz P, Dunbar JA, Reddy P, O’Neil A. The spread and uptake of diabetes prevention programs around the world: a case study from Finland and Australia. Transl Behav Med. 2011 Jun;1(2):270–82.
- Saaristo T, Moilanen L, Korpi-Hyövälti E, Vanhala M, Saltevo J, Niskanen L, et al. Lifestyle Intervention for Prevention of Type 2 Diabetes in Primary Health Care. Diabetes Care. 2010 Oct;33(10):2146–51.